Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Piramal Pharma Limited ( (IN:PPLPHARMA) ) has issued an update.
Piramal Pharma Limited has expanded its senior management ranks by designating four executives as Senior Management Personnel, covering key functions such as quality, mergers and acquisitions, legal, and human resources, reflecting a push to strengthen governance and operational leadership across critical verticals. The company also announced a change in its key managerial personnel, with Company Secretary and Compliance Officer Tanya Sanish resigning effective 20 February 2026 and the Board appointing Pratibha Mishra as Interim Company Secretary and Compliance Officer from 21 February 2026, ensuring continuity in corporate compliance and regulatory oversight.
More about Piramal Pharma Limited
Piramal Pharma Limited is an India-based pharmaceutical company focused on providing a range of pharma products and services, operating across segments such as contract development and manufacturing, complex hospital generics, and consumer healthcare, with a presence in domestic and international markets.
Average Trading Volume: 222,676
Technical Sentiment Signal: Sell
Current Market Cap: 201.2B INR
For an in-depth examination of PPLPHARMA stock, go to TipRanks’ Overview page.